Corpus Engine Towards a reproducible .science file.
← All .science files

pmid:33225420

Distinct clinical and biological characteristics of acute myeloid leukemia with higher expression of long noncoding RNA KIAA0125.

Yu-Hung Wang · Chien-Chin Lin · Chia-Lang Hsu · Sheng-Yu Hung · Chi-Yuan Yao · Sze-Hwei Lee · Cheng-Hong Tsai · Hsin-An Hou · Wen-Chien Chou · Hwei-Fang Tien

Annals of hematology · 2021 doi:10.1007/s00277-020-04358-y

Paper

complete

Experiment

partial

Data

partial

Analysis

partial

Execution

absent

Execution evidence has not yet been added to this .science file. Explore its methods, data and open questions to plan the next step.
Record details sci_version · id · kind · revision · content_hash · schema · created_at · updated_at · generator
id
pmid:33225420
kind
science-record
content_hash
sha256:d0db96be72a70f81e8b122db3d8d4e5f3c1dea48364f1df592a1463d635ef124
schema
https://corpus.bntrg.co.uk/sci/1.0/sci.schema.json
created_at
2026-11-01T15:41:16Z
updated_at
2026-11-01T22:02:34Z
generator object · 2 fields
name
corpus-assay-engine
run_id
reading-sci-2026-11-01
paper object · 10 fields
state
complete
title
Distinct clinical and biological characteristics of acute myeloid leukemia with higher expression of long noncoding RNA KIAA0125.
doi
10.1007/s00277-020-04358-y
pmid
33225420
authors array · 10 items
[0]
Yu-Hung Wang
[1]
Chien-Chin Lin
[2]
Chia-Lang Hsu
[3]
Sheng-Yu Hung
[4]
Chi-Yuan Yao
[5]
Sze-Hwei Lee
[6]
Cheng-Hong Tsai
[7]
Hsin-An Hou
[8]
Wen-Chien Chou
[9]
Hwei-Fang Tien
journal
Annals of hematology
year
2021
abstract
Expression of long non-coding RNA KIAA0125 has been incorporated in various gene expression signatures for prognostic prediction in acute myeloid leukemia (AML) patients, yet its functions and clinical significance remain unclear. This study aimed to investigate the clinical and biological characteristics of AML bearing different levels of KIAA0125. We profiled KIAA0125 expression levels in bone marrow cells from 347 de novo AML patients and found higher KIAA0125 expression was closely associated with RUNX1 mutation, but inversely correlated with t(8;21) and t(15;17) karyotypes. Among the 227 patients who received standard chemotherapy, those with higher KIAA0125 expression had a lower complete remission rate, shorter overall survival (OS) and disease-free survival (DFS) than those with lower expression. The prognostic significance was validated in both TCGA and GSE12417 cohorts. Subgroup analyses showed that higher KIAA0125 expression also predicted shorter DFS and OS in patients with normal karyotype or non-M3 AML. In multivariable analysis, higher KIAA0125 expression remained an adverse risk factor independent of age, WBC counts, karyotypes, and mutation patterns. Bioinformatics analyses revealed that higher KIAA0125 expression was associated with hematopoietic and leukemic stem cell signatures and ATP-binding cassette transporters, two predisposing factors for chemoresistance.
claims array · 2 items
[0] object · 6 fields
id
claim-method
statement
To find the optimal cutoff for separating patient groups, we used maximally selected rank statistics implemented in the maxstat R package.
kind
methodological
target
null
evidence array · 1 item
[0] object · 3 fields
asset
source:pmid:33225420
locator
sections[7] "Statistical analysis" paragraph 2
quote
To find the optimal cutoff for separating patient groups, we used maximally selected rank statistics implemented in the maxstat R package.
state
complete
[1] object · 6 fields
id
claim-data-access
statement
The raw and normalized microarray data reported in this article have been deposited in the Gene Expression Omnibus database (accession number GSE68469 and GSE71014).
kind
methodological
target
null
evidence array · 1 item
[0] object · 3 fields
asset
source:pmid:33225420
locator
sections[18] "Data availability statement" paragraph 2
quote
The raw and normalized microarray data reported in this article have been deposited in the Gene Expression Omnibus database (accession number GSE68469 and GSE71014).
state
complete
gaps array · 0 items
experiment object · 8 fields
state
partial
objective
null
steps array · 3 items
[0] object · 13 fields
id
read_published_estimate
order
1
name
Read the published estimate from the source
kind
other
state
complete
blocked_on
null
description
The claim, method and evidence span published with the source article.
parameters object · 0 fields
inputs array · 1 item
[0]
source:pmid:33225420
outputs array · 1 item
[0]
the published estimate and its evidence
instruments array · 0 items
reagents array · 0 items
[1] object · 13 fields
id
obtain_source_data
order
2
name
Obtain the source data from the named repository
kind
data-preparation
state
blocked
blocked_on
data:accession_absent
description
The GEO series accession resolves and its sample accessions are listed. This lane did not download the dataset or read its licence.
parameters object · 0 fields
inputs array · 0 items
outputs array · 1 item
[0]
the source data with its repository provenance
instruments array · 0 items
reagents array · 0 items
[2] object · 13 fields
id
run_analysis
order
3
name
Run the published analysis
kind
analysis
state
blocked
blocked_on
method:group_comparison_mann_whitney
description
Apply the paper's statistical method to the resolved series and compare the result with the published target.
parameters object · 0 fields
inputs array · 0 items
outputs array · 1 item
[0]
the replicated result and its comparison
instruments array · 0 items
reagents array · 0 items
materials array · 0 items
instruments array · 0 items
reagents array · 0 items
conditions object · 0 fields
gaps array · 2 items
[0]
step:run_analysis blocked on method:group_comparison_mann_whitney
[1]
step:obtain_source_data blocked on data:accession_absent
data object · 3 fields
state
partial
assets array · 4 items
[0] object · 15 fields
id
source:pmid:33225420
role
manuscript
format
xml
media_type
application/xml
uri
https://doi.org/10.1007/s00277-020-04358-y
sha256
sha256:de316a2b0cce58603031ef704d6c42bae71dbedbb3693c45138ec43bed61249c
bytes
43724
access
open
state
resolved
reader
null
reader_status
reader_required
identifier
10.1007/s00277-020-04358-y
version
null
note
Full article fetched from PMC; the checksum covers the rendered section body, not the original XML bytes.
structure object · 4 fields
pmcid
PMC7817567
source
europe_pmc_fulltext
coverage
whole_body
text_hash_scope
rendered_section_body
[1] object · 16 fields
id
asset:table:pmid:33225420:1
role
table
format
jats-table
media_type
application/vnd.jats.table+json
uri
null
sha256
sha256:13eed8e3cf3de6c415d8df36acac62a8f6b9f6e102447c92a7aa1fe0c945f1a4
bytes
1738
access
open
state
verified
reader
read_table
reader_status
available
identifier
section[8]/table-wrap[1]#Tab1
version
null
note
Comparison of clinical and laboratory features between AML patients with lower and higher BM KIAA0125 expression
structure object · 5 fields
pmcid
PMC7817567
section_index
8
section_title
Results
row_count
27
column_count
5
table object · 8 fields
label
Table 1
caption
Comparison of clinical and laboratory features between AML patients with lower and higher BM KIAA0125 expression
rows array · 27 items
[0] array · 5 items
[0]
Clinical characters
[1]
Total (N = 347)
[2]
High KIAA0125 (n = 174)
[3]
Low KIAA0125 (n = 173)
[4]
P value
[1] array · 5 items
[0]
Sex
[1]
[2]
[3]
[4]
0.174
[2] array · 5 items
[0]
Male
[1]
196
[2]
92
[3]
104
[4]
[3] array · 5 items
[0]
Female
[1]
151
[2]
82
[3]
69
[4]
[4] array · 5 items
[0]
Age*
[1]
[2]
57 (15–91)
[3]
58 (18–90)
[4]
0.830
[5] array · 1 item
[0]
Laboratory data*
[6] array · 5 items
[0]
WBC, X 109 /L
[1]
21.9 (0.38–423)
[2]
21.4 (0.38–417.5)
[3]
22.38 (0.65–423.0)
[4]
0.872
[7] array · 5 items
[0]
Hb, g/dL
[1]
8.1 (3.3–16.2)
[2]
8.1 (3.3–13.2)
[3]
8.1 (3.7–16.2)
[4]
0.959
[8] array · 5 items
[0]
Platelet, X 109 /L
[1]
45 (2–655)
[2]
54 (6–455)
[3]
41 (2–655)
[4]
0.060
[9] array · 5 items
[0]
Blast, X 109 /L
[1]
9.1 (0–369.1)
[2]
12.3 (0–345.9)
[3]
5.7 (0–369.1)
[4]
0.021
[10] array · 5 items
[0]
LDH (U/L)
[1]
917 (202–13,130)
[2]
892.5 (242–7734)
[3]
925 (202–13,130)
[4]
0.787
[11] array · 1 item
[0]
Risk groups
[12] array · 5 items
[0]
t(8;21)
[1]
24
[2]
0 (0)
[3]
24 (14.3)
[4]
< 0.001
[13] array · 5 items
[0]
t(15;17)
[1]
27
[2]
3 (1.8)
[3]
24 (14.3)
[4]
< 0.001
[14] array · 5 items
[0]
inv(16)
[1]
9
[2]
6 (3.7)
[3]
3 (1.8)
[4]
0.332
[15] array · 5 items
[0]
CEBPAdouble
[1]
27
[2]
13 (48.1)
[3]
14 (51.9)
[4]
0.829
[16] array · 5 items
[0]
NPM1+/FLT3-ITD-
[1]
57
[2]
32 (18.4)
[3]
25 (14.5)
[4]
0.385
[17] array · 5 items
[0]
NPM1-/FLT3-ITD+
[1]
19
[2]
3 (1.7)
[3]
16 (9.2)
[4]
0.002
[18] array · 5 items
[0]
RUNX1
[1]
50
[2]
32 (64)
[3]
18 (36)
[4]
0.034
[19] array · 5 items
[0]
ASXL1
[1]
52
[2]
26 (50)
[3]
26 (50)
[4]
0.982
[20] array · 5 items
[0]
Unfavorable karyotypes†‡
[1]
49
[2]
30 (18.3)
[3]
19 (11.3)
[4]
0.089
[21] array · 5 items
[0]
Induction response, n (%)
[1]
227
[2]
116
[3]
111
[4]
[22] array · 5 items
[0]
CR
[1]
165 (72.7)
[2]
71 (61.2)
[3]
94 (84.7)
[4]
< 0.001
[23] array · 5 items
[0]
PR
[1]
5 (2.2)
[2]
4 (3.4)
[3]
1 (0.9)
[4]
0.191
[24] array · 5 items
[0]
Refractory
[1]
42 (18.5)
[2]
33 (28.4)
[3]
9 (8.1)
[4]
< 0.001
[25] array · 5 items
[0]
Induction death
[1]
15 (6.6)
[2]
8 (6.9)
[3]
7 (6.3)
[4]
0.858
[26] array · 5 items
[0]
Relapse (%)
[1]
72 (31.7)
[2]
42 (36.2)
[3]
30 (27.0)
[4]
0.137
locator
section[8]/table-wrap[1]#Tab1
[2] object · 16 fields
id
asset:table:pmid:33225420:2
role
table
format
jats-table
media_type
application/vnd.jats.table+json
uri
null
sha256
sha256:f600bd214bf76d608301bb7616efbc2c6d10e9512662b708a13a350428f8b4b7
bytes
1067
access
open
state
verified
reader
read_table
reader_status
available
identifier
section[10]/table-wrap[1]#Tab2
version
null
note
Multivariable analysis for DFS and OS in 227 AML patients who received standard intensive chemotherapy
structure object · 5 fields
pmcid
PMC7817567
section_index
10
section_title
The impacts of the KIAA0125 expression on OS and DFS
row_count
12
column_count
9
table object · 8 fields
label
Table 2
caption
Multivariable analysis for DFS and OS in 227 AML patients who received standard intensive chemotherapy
rows array · 12 items
[0] array · 3 items
[0]
[1]
DFS
[2]
OS
[1] array · 2 items
[0]
95% CI
[1]
95% CI
[2] array · 9 items
[0]
Variable
[1]
HR
[2]
Lower
[3]
Upper
[4]
P
[5]
HR
[6]
Lower
[7]
Upper
[8]
P
[3] array · 9 items
[0]
Age*
[1]
1.007
[2]
0.995
[3]
1.019
[4]
0.253
[5]
1.030
[6]
1.014
[7]
1.047
[8]
< 0.001
[4] array · 9 items
[0]
WBC*
[1]
1.004
[2]
1.002
[3]
1.007
[4]
0.001
[5]
1.005
[6]
1.001
[7]
1.008
[8]
0.012
[5] array · 9 items
[0]
Karyotype†
[1]
1.610
[2]
1.201
[3]
2.160
[4]
0.001
[5]
1.706
[6]
1.158
[7]
2.513
[8]
0.007
[6] array · 9 items
[0]
NPM1/FLT3-ITD‡
[1]
0.601
[2]
0.332
[3]
1.089
[4]
0.093
[5]
0.895
[6]
0.443
[7]
1.808
[8]
0.757
[7] array · 9 items
[0]
CEBPAdouble
[1]
0.598
[2]
0.286
[3]
1.252
[4]
0.173
[5]
0.451
[6]
0.137
[7]
1.488
[8]
0.191
[8] array · 9 items
[0]
RUNX1
[1]
1.532
[2]
0.875
[3]
2.683
[4]
0.136
[5]
1.432
[6]
0.726
[7]
2.821
[8]
0.300
[9] array · 9 items
[0]
MLL-PTD
[1]
2.706
[2]
1.263
[3]
5.799
[4]
0.010
[5]
2.882
[6]
1.077
[7]
7.710
[8]
0.035
[10] array · 9 items
[0]
TP53
[1]
1.918
[2]
0.697
[3]
5.283
[4]
0.207
[5]
3.030
[6]
0.956
[7]
9.608
[8]
0.060
[11] array · 9 items
[0]
Higher KIAA0125 expression§
[1]
2.300
[2]
1.569
[3]
3.371
[4]
<0.001
[5]
2.188
[6]
1.317
[7]
3.636
[8]
0.003
locator
section[10]/table-wrap[1]#Tab2
[3] object · 16 fields
id
asset:table:pmid:33225420:3
role
table
format
jats-table
media_type
application/vnd.jats.table+json
uri
null
sha256
sha256:0489e3386bf9793c70cbe77627aa29617cbd34e5c2ce50ba5cf7523ebec575aa
bytes
2800
access
open
state
verified
reader
read_table
reader_status
available
identifier
section[11]/table-wrap[1]#Tab3
version
null
note
Summary of the biological functions of the KIAA0125-associated genes that have been reported to be associated with prognosis or drug resistance in AML patients and their correlation values with KIAA0125 in ours and the TCGA cohorts
structure object · 5 fields
pmcid
PMC7817567
section_index
11
section_title
Biological impacts of KIAA0125 in AML
row_count
16
column_count
6
table object · 8 fields
label
Table 3
caption
Summary of the biological functions of the KIAA0125-associated genes that have been reported to be associated with prognosis or drug resistance in AML patients and their correlation values with KIAA0125 in ours and the TCGA cohorts
rows array · 16 items
[0] array · 3 items
[0]
Genes
[1]
Correlation coefficient (p value)
[2]
Association with leukemia
[1] array · 2 items
[0]
NTUH
[1]
TCGA
[2] array · 6 items
[0]
SPINK2
[1]
0.661
[2]
(3.4E-45)
[3]
0.5798
[4]
(6.2E-15)
[5]
Serine Peptidase Inhibitor; upregulation is associated with poor outcomes in adult patients with AML [30]; integrated into a 6-gene LSC score to identifies high risk pediatric AML [31]
[3] array · 6 items
[0]
MAP7
[1]
0.653
[2]
1.0E-43
[3]
0.696
[4]
(<E-45)
[5]
Microtubule-associated proteins, overexpressed in cytogenetically normal AML patients with dismal outcomes [32]
[4] array · 6 items
[0]
HOPX
[1]
0.619
[2]
(2.6E-38)
[3]
0.643
[4]
(<E-45)
[5]
The smallest homeodomain protein; higher expression predicts poor prognosis in de novo AML [33]
[5] array · 6 items
[0]
MMRN1
[1]
0.609
[2]
(9.7E-37)
[3]
0.597
[4]
(<E-45)
[5]
A member of the elastin microfibrillar interface protein; an adverse marker in both pediatric and adult AML [34]
[6] array · 6 items
[0]
DNMT3B
[1]
0.599
[2]
(1.7E-35)
[3]
0.631
[4]
(<E-45)
[5]
DNA methyltransferases; an important LSC marker [35–37]
[7] array · 6 items
[0]
TCF4
[1]
0.556
[2]
(1.1E-29)
[3]
0.626
[4]
(<E-45)
[5]
A transcription factor; predict outcome in RUNX1 mutated and translocated AML [38, 39]
[8] array · 6 items
[0]
SLC38A1
[1]
0.536
[2]
(2.3E-27)
[3]
0.585
[4]
(<E-45)
[5]
A glutamine amino acid transporter, overexpressed in AML patients with adverse clinical outcomes [40]
[9] array · 6 items
[0]
DOCK1
[1]
0.530
[2]
(1.1E-26)
[3]
0.597
[4]
(5.9E-16)
[5]
A novel class of guanine nucleotide exchange factors; high expression confers poor prognosis in AML [41]
[10] array · 6 items
[0]
ARHGAP22
[1]
0.519
[2]
(1.5E-25)
[3]
0.518
[4]
(<E-45)
[5]
Rho GTPase activating protein, incorporated in the 17-gene LSC score which predicts treatment response in AML [9]
[11] array · 6 items
[0]
MN1
[1]
0.502
[2]
(1.1E-23)
[3]
0.565
[4]
(<E-45)
[5]
A transcriptional coactivator, overexpression could induce AML in mice and predict ATRA resistance in human AML patients [42, 43]
[12] array · 6 items
[0]
ABCG1
[1]
0.504
[2]
(6.7E-24)
[3]
0.610
[4]
(<E-45)
[5]
Belongs to ATP-binding cassette (ABC) superfamily; responsible for important chemoresistance mechanism in AML [44–49]
[13] array · 6 items
[0]
ABCA2
[1]
0.367
[2]
(1.5E-12)
[3]
0.507
[4]
(2.3E-11)
[5]
Belongs to ATP-binding cassette (ABC) superfamily; a strong prognostic biomarker for multidrug resistance in pediatric acute lymphoblastic leukemia [44–49]
[14] array · 6 items
[0]
ABCB1
[1]
0.353
[2]
(1.2E-11)
[3]
0.364
[4]
(5.2E-6)
[5]
Belongs to ATP-binding cassette (ABC) superfamily; responsible for important chemoresistance mechanism in AML [44–49]
[15] array · 6 items
[0]
ABCC1
[1]
0.310
[2]
(3.2E-9)
[3]
0.458
[4]
(5.2E-9)
[5]
Belongs to ATP-binding cassette (ABC) superfamily; responsible for important chemoresistance mechanism in AML [44–49]
locator
section[11]/table-wrap[1]#Tab3
gaps array · 0 items
analysis object · 4 fields
state
partial
methods array · 7 items
[0] object · 10 fields
id
method-1
family
group_comparison
specific
mann_whitney
label
Group comparison
dsl_operations array · 0 items
missing_operations array · 1 item
[0]
group_comparison_mann_whitney
expressible
false
parameters object · 0 fields
data_shapes array · 1 item
[0]
two_or_more_groups_continuous
evidence object · 3 fields
score
0.8
band
high
quote
Mann-Whitney
[1] object · 10 fields
id
method-2
family
group_comparison
specific
anova
label
Group comparison
dsl_operations array · 4 items
[0]
group_summary
[1]
welch_t
[2]
bootstrap_mean_difference
[3]
group_comparison_anova
missing_operations array · 0 items
parameters object · 0 fields
data_shapes array · 1 item
[0]
two_or_more_groups_continuous
evidence object · 3 fields
score
0.8
band
high
quote
ANOVA
[2] object · 10 fields
id
method-3
family
survival_analysis
specific
kaplan_meier
label
Survival analysis
dsl_operations array · 1 item
[0]
survival_km
missing_operations array · 0 items
parameters object · 0 fields
data_shapes array · 1 item
[0]
time_to_event_with_censoring
evidence object · 3 fields
score
0.8
band
high
quote
Kaplan-Meier
[3] object · 10 fields
id
method-4
family
survival_analysis
specific
cox_proportional_hazards
label
Survival analysis
dsl_operations array · 1 item
[0]
cox_ph
missing_operations array · 0 items
parameters object · 0 fields
data_shapes array · 1 item
[0]
time_to_event_with_censoring
evidence object · 3 fields
score
0.8
band
high
quote
Cox proportional hazards
[4] object · 10 fields
id
method-5
family
survival_analysis
specific
log_rank_test
label
Survival analysis
dsl_operations array · 1 item
[0]
logrank_test
missing_operations array · 0 items
parameters object · 0 fields
data_shapes array · 1 item
[0]
time_to_event_with_censoring
evidence object · 3 fields
score
0.8
band
high
quote
log-rank
[5] object · 10 fields
id
method-6
family
contingency_analysis
specific
chi_square
label
Categorical (contingency table) analysis
dsl_operations array · 1 item
[0]
chi_square_test
missing_operations array · 0 items
parameters object · 0 fields
data_shapes array · 1 item
[0]
categorical_cross_tabulation
evidence object · 3 fields
score
0.8
band
high
quote
χ2
[6] object · 10 fields
id
method-7
family
null
specific
null
label
Maximally selected rank statistics were used to determine the optimal KIAA0125-expression cutoff for separating high- and low-expression patient groups.
dsl_operations array · 0 items
missing_operations array · 0 items
parameters object · 0 fields
data_shapes array · 0 items
evidence object · 3 fields
score
1
band
verbatim
quote
To find the optimal cutoff for separating patient groups, we used maximally selected rank statistics implemented in the maxstat R package.
targets array · 0 items
gaps array · 2 items
[0]
method.reader_named_unmapped
[1]
method.group_comparison_mann_whitney
capability object · 3 fields
state
complete
requirements array · 1 item
[0] object · 6 fields
capability_id
capability:computational_analysis
label
Computational analysis platform
assay_families array · 9 items
[0]
meta_analysis
[1]
machine_learning
[2]
survival_analysis
[3]
statistical_regression
[4]
pca
[5]
molecular_docking
[6]
network_analysis
[7]
differential_expression
[8]
gwas
candidate
Automated Assays Laravel application and simulated adapters
gaps array · 0 items
readiness object · 8 fields
state
blocked
tier
R4
blocked_on
data:accession_absent
axes object · 3 fields
method object · 5 fields
tier
R1
expressible
false
required_operations array · 0 items
missing_operations array · 1 item
[0]
group_comparison_mann_whitney
basis
The paper names the method it used and the corpus's method extractor maps it onto the DSL catalogue: mann_whitney.
capability object · 4 fields
tier
R1
capability_id
capability:computational_analysis
availability_state
owned
basis
The computational analysis is owned. The physical bench the paper used is not, so a physical validation cannot be run here.
data object · 6 fields
tier
R4
reachable
false
accessions array · 2 items
[0]
GSE68469 and GSE71014
[1]
GSE12417-GPL96
resolved_accessions array · 0 items
statements array · 1 item
[0]
The raw and normalized microarray data reported in this article have been deposited in the Gene Expression Omnibus database (accession number GSE68469 and GSE71014).
basis
The paper names GSE68469 and GSE71014, GSE12417-GPL96, but the accession does not resolve in the repository (no reason recorded, no reason recorded), so the data cannot be reached from here. No dataset was downloaded and no licence was read.
can_run object · 3 fields
dsl_operations array · 0 items
assets array · 4 items
[0]
source:pmid:33225420
[1]
asset:table:pmid:33225420:1
[2]
asset:table:pmid:33225420:2
[3]
asset:table:pmid:33225420:3
steps array · 0 items
must_build object · 5 fields
dsl_operations array · 1 item
[0] object · 3 fields
operation
group_comparison_mann_whitney
priority
null
converters array · 0 items
readers array · 0 items
capabilities array · 0 items
data_gaps array · 1 item
[0]
data:geo:None
gaps array · 1 item
[0]
data:accession_absent
review object · 5 fields
state
partial
machine_critique object · 5 fields
kind
extraction_review
reader object · 5 fields
model
MiniMax-M3.1-Flash
provider
minimax
provider_family
minimax
read_at
2026-10-31T18:24:32Z
independence
single_reader
evidence_check object · 2 fields
method
verbatim
availability
verbatim
calls
3
usage object · 3 fields
prompt_tokens
38815
completion_tokens
1616
cached_tokens
793
stages array · 1 item
[0] object · 4 fields
id
extraction
state
complete
reader
MiniMax-M3.1-Flash
provider
minimax
gaps array · 3 items
[0]
review.independent_reader
[1]
review.machine_critique
[2]
review.human_critique
execution object · 5 fields
state
absent
status
not_run
mode
null
runs array · 0 items
gaps array · 1 item
[0]
execution.not_run
provenance object · 7 fields
entities array · 3 items
[0] object · 3 fields
id
pmid:33225420
type
paper
label
pmid:33225420
[1] object · 3 fields
id
source:pmid:33225420
type
manuscript
label
PMID 33225420 full text
[2] object · 3 fields
id
data:geo:None
type
dataset
label
GEO None
activities array · 3 items
[0] object · 4 fields
id
activity-reading-sci-2026-11-01
type
classification
used array · 3 items
[0] object · 3 fields
id
pmid:33225420
type
paper
label
pmid:33225420
[1] object · 3 fields
id
source:pmid:33225420
type
manuscript
label
PMID 33225420 full text
[2] object · 3 fields
id
data:geo:None
type
dataset
label
GEO None
agent
agent:corpus-assay-engine
[1] object · 4 fields
id
activity-read-33225420
type
extraction
used array · 1 item
[0]
source:pmid:33225420
agent
agent:minimax-reader
[2] object · 4 fields
id
activity-resolve-None
type
accession_resolution
used array · 1 item
[0]
data:geo:None
agent
agent:corpus-assay-engine
agents array · 2 items
[0] object · 3 fields
id
agent:corpus-assay-engine
type
software
label
Corpus assay engine
[1] object · 3 fields
id
agent:minimax-reader
type
software
label
MiniMax literature reader
source_run_id
reading-sci-2026-11-01
dsl_catalogue_fingerprint
343fb30756ba6ec3
capability_table_fingerprint
2cb3e42f047d2ecf
snapshot_id
ba34b49490d9bfaf
lineage object · 4 fields
parent_id
pmid:33225420
parent_hash
sha256:438dfcd9610901565ae1f0822354b2b2195554ef2584e0879182db6bccd8f527
fork_of
null
gaps array · 8 items
[0]
execution.not_run
[1]
method.group_comparison_mann_whitney
[2]
method.reader_named_unmapped
[3]
review.human_critique
[4]
review.independent_reader
[5]
review.machine_critique
[6]
step:obtain_source_data blocked on data:accession_absent
[7]
step:run_analysis blocked on method:group_comparison_mann_whitney
assays array · 3 items
[0] object · 11 fields
role
data_generation
definition_id
amplicon_seq
definition_version
99e1195c7d6f
required_operations array · 0 items
support_state
partial
source_hashes object · 1 field
assay_lexicon
99e1195c7d6f
confidence
0.93
evidence array · 1 item
[0]
participants. Analysis of gene expression in next-generation sequencing datasets We analyzed gene expression data of
order_basis
paper_text_order:2797
id
assay:1
[1] object · 11 fields
role
data_generation
definition_id
rna_seq
definition_version
99e1195c7d6f
required_operations array · 0 items
support_state
partial
source_hashes object · 1 field
assay_lexicon
99e1195c7d6f
confidence
0.93
evidence array · 1 item
[0]
mples profiled with Illumina Genome Analyzer RNA Sequencing in the TCGA database [30] to investigate the
order_basis
paper_text_order:2924
id
assay:2
[2] object · 11 fields
role
analysis
definition_id
group_comparison
definition_version
f2132e96ae6c7a4e
required_operations array · 0 items
support_state
partial
source_hashes object · 1 field
dsl_catalogue
f2132e96ae6c7a4e
evidence array · 1 item
[0]
Mann-Whitney
order_basis
consumes_earlier_output
id
assay:3
Complete file
{"sci_version": "1.2", "schema": "https://corpus.bntrg.co.uk/sci/1.0/sci.schema.json", "id": "pmid:33225420", "kind": "science-record", "revision": 7, "content_hash": "sha256:d0db96be72a70f81e8b122db3d8d4e5f3c1dea48364f1df592a1463d635ef124", "created_at": "2026-11-01T15:41:16Z", "updated_at": "2026-11-01T22:02:34Z", "generator": {"name": "corpus-assay-engine", "run_id": "reading-sci-2026-11-01"}, "paper": {"state": "complete", "title": "Distinct clinical and biological characteristics of acute myeloid leukemia with higher expression of long noncoding RNA KIAA0125.", "doi": "10.1007/s00277-020-04358-y", "pmid": "33225420", "authors": ["Yu-Hung Wang", "Chien-Chin Lin", "Chia-Lang Hsu", "Sheng-Yu Hung", "Chi-Yuan Yao", "Sze-Hwei Lee", "Cheng-Hong Tsai", "Hsin-An Hou", "Wen-Chien Chou", "Hwei-Fang Tien"], "journal": "Annals of hematology", "year": 2021, "abstract": "Expression of long non-coding RNA KIAA0125 has been incorporated in various gene expression signatures for prognostic prediction in acute myeloid leukemia (AML) patients, yet its functions and clinical significance remain unclear. This study aimed to investigate the clinical and biological characteristics of AML bearing different levels of KIAA0125. We profiled KIAA0125 expression levels in bone marrow cells from 347 de novo AML patients and found higher KIAA0125 expression was closely associated with RUNX1 mutation, but inversely correlated with t(8;21) and t(15;17) karyotypes. Among the 227 patients who received standard chemotherapy, those with higher KIAA0125 expression had a lower complete remission rate, shorter overall survival (OS) and disease-free survival (DFS) than those with lower expression. The prognostic significance was validated in both TCGA and GSE12417 cohorts. Subgroup analyses showed that higher KIAA0125 expression also predicted shorter DFS and OS in patients with normal karyotype or non-M3 AML. In multivariable analysis, higher KIAA0125 expression remained an adverse risk factor independent of age, WBC counts, karyotypes, and mutation patterns. Bioinformatics analyses revealed that higher KIAA0125 expression was associated with hematopoietic and leukemic stem cell signatures and ATP-binding cassette transporters, two predisposing factors for chemoresistance.", "claims": [{"id": "claim-method", "statement": "To find the optimal cutoff for separating patient groups, we used maximally selected rank statistics implemented in the maxstat R package.", "kind": "methodological", "target": null, "evidence": [{"asset": "source:pmid:33225420", "locator": "sections[7] \"Statistical analysis\" paragraph 2", "quote": "To find the optimal cutoff for separating patient groups, we used maximally selected rank statistics implemented in the maxstat R package."}], "state": "complete"}, {"id": "claim-data-access", "statement": "The raw and normalized microarray data reported in this article have been deposited in the Gene Expression Omnibus database (accession number GSE68469 and GSE71014).", "kind": "methodological", "target": null, "evidence": [{"asset": "source:pmid:33225420", "locator": "sections[18] \"Data availability statement\" paragraph 2", "quote": "The raw and normalized microarray data reported in this article have been deposited in the Gene Expression Omnibus database (accession number GSE68469 and GSE71014)."}], "state": "complete"}], "gaps": []}, "experiment": {"state": "partial", "objective": null, "steps": [{"id": "read_published_estimate", "order": 1, "name": "Read the published estimate from the source", "kind": "other", "state": "complete", "blocked_on": null, "description": "The claim, method and evidence span published with the source article.", "duration_hours": null, "parameters": {}, "inputs": ["source:pmid:33225420"], "outputs": ["the published estimate and its evidence"], "instruments": [], "reagents": []}, {"id": "obtain_source_data", "order": 2, "name": "Obtain the source data from the named repository", "kind": "data-preparation", "state": "blocked", "blocked_on": "data:accession_absent", "description": "The GEO series accession resolves and its sample accessions are listed. This lane did not download the dataset or read its licence.", "duration_hours": null, "parameters": {}, "inputs": [], "outputs": ["the source data with its repository provenance"], "instruments": [], "reagents": []}, {"id": "run_analysis", "order": 3, "name": "Run the published analysis", "kind": "analysis", "state": "blocked", "blocked_on": "method:group_comparison_mann_whitney", "description": "Apply the paper's statistical method to the resolved series and compare the result with the published target.", "duration_hours": null, "parameters": {}, "inputs": [], "outputs": ["the replicated result and its comparison"], "instruments": [], "reagents": []}], "materials": [], "instruments": [], "reagents": [], "conditions": {}, "gaps": ["step:run_analysis blocked on method:group_comparison_mann_whitney", "step:obtain_source_data blocked on data:accession_absent"]}, "data": {"state": "partial", "assets": [{"id": "source:pmid:33225420", "role": "manuscript", "format": "xml", "media_type": "application/xml", "uri": "https://doi.org/10.1007/s00277-020-04358-y", "sha256": "sha256:de316a2b0cce58603031ef704d6c42bae71dbedbb3693c45138ec43bed61249c", "bytes": 43724, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "10.1007/s00277-020-04358-y", "version": null, "note": "Full article fetched from PMC; the checksum covers the rendered section body, not the original XML bytes.", "structure": {"pmcid": "PMC7817567", "source": "europe_pmc_fulltext", "coverage": "whole_body", "text_hash_scope": "rendered_section_body"}}, {"id": "asset:table:pmid:33225420:1", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:13eed8e3cf3de6c415d8df36acac62a8f6b9f6e102447c92a7aa1fe0c945f1a4", "bytes": 1738, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[8]/table-wrap[1]#Tab1", "version": null, "note": "Comparison of clinical and laboratory features between AML patients with lower and higher BM KIAA0125 expression", "structure": {"pmcid": "PMC7817567", "section_index": 8, "section_title": "Results", "row_count": 27, "column_count": 5}, "table": {"label": "Table 1", "caption": "Comparison of clinical and laboratory features between AML patients with lower and higher BM KIAA0125 expression", "rows": [["Clinical characters", "Total (N = 347)", "High KIAA0125 (n = 174)", "Low KIAA0125 (n = 173)", "P value"], ["Sex", "", "", "", "0.174"], ["Male", "196", "92", "104", ""], ["Female", "151", "82", "69", ""], ["Age*", "", "57 (15–91)", "58 (18–90)", "0.830"], ["Laboratory data*"], ["WBC, X 109 /L", "21.9 (0.38–423)", "21.4 (0.38–417.5)", "22.38 (0.65–423.0)", "0.872"], ["Hb, g/dL", "8.1 (3.3–16.2)", "8.1 (3.3–13.2)", "8.1 (3.7–16.2)", "0.959"], ["Platelet, X 109 /L", "45 (2–655)", "54 (6–455)", "41 (2–655)", "0.060"], ["Blast, X 109 /L", "9.1 (0–369.1)", "12.3 (0–345.9)", "5.7 (0–369.1)", "0.021"], ["LDH (U/L)", "917 (202–13,130)", "892.5 (242–7734)", "925 (202–13,130)", "0.787"], ["Risk groups"], ["t(8;21)", "24", "0 (0)", "24 (14.3)", "< 0.001"], ["t(15;17)", "27", "3 (1.8)", "24 (14.3)", "< 0.001"], ["inv(16)", "9", "6 (3.7)", "3 (1.8)", "0.332"], ["CEBPAdouble", "27", "13 (48.1)", "14 (51.9)", "0.829"], ["NPM1+/FLT3-ITD-", "57", "32 (18.4)", "25 (14.5)", "0.385"], ["NPM1-/FLT3-ITD+", "19", "3 (1.7)", "16 (9.2)", "0.002"], ["RUNX1", "50", "32 (64)", "18 (36)", "0.034"], ["ASXL1", "52", "26 (50)", "26 (50)", "0.982"], ["Unfavorable karyotypes†‡", "49", "30 (18.3)", "19 (11.3)", "0.089"], ["Induction response, n (%)", "227", "116", "111", ""], ["CR", "165 (72.7)", "71 (61.2)", "94 (84.7)", "< 0.001"], ["PR", "5 (2.2)", "4 (3.4)", "1 (0.9)", "0.191"], ["Refractory", "42 (18.5)", "33 (28.4)", "9 (8.1)", "< 0.001"], ["Induction death", "15 (6.6)", "8 (6.9)", "7 (6.3)", "0.858"], ["Relapse (%)", "72 (31.7)", "42 (36.2)", "30 (27.0)", "0.137"]], "row_count": 27, "column_count": 5, "numeric_cells": 98, "header_rows": 1, "locator": "section[8]/table-wrap[1]#Tab1"}}, {"id": "asset:table:pmid:33225420:2", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:f600bd214bf76d608301bb7616efbc2c6d10e9512662b708a13a350428f8b4b7", "bytes": 1067, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[10]/table-wrap[1]#Tab2", "version": null, "note": "Multivariable analysis for DFS and OS in 227 AML patients who received standard intensive chemotherapy", "structure": {"pmcid": "PMC7817567", "section_index": 10, "section_title": "The impacts of the KIAA0125 expression on OS and DFS", "row_count": 12, "column_count": 9}, "table": {"label": "Table 2", "caption": "Multivariable analysis for DFS and OS in 227 AML patients who received standard intensive chemotherapy", "rows": [["", "DFS", "OS"], ["95% CI", "95% CI"], ["Variable", "HR", "Lower", "Upper", "P", "HR", "Lower", "Upper", "P"], ["Age*", "1.007", "0.995", "1.019", "0.253", "1.030", "1.014", "1.047", "< 0.001"], ["WBC*", "1.004", "1.002", "1.007", "0.001", "1.005", "1.001", "1.008", "0.012"], ["Karyotype†", "1.610", "1.201", "2.160", "0.001", "1.706", "1.158", "2.513", "0.007"], ["NPM1/FLT3-ITD‡", "0.601", "0.332", "1.089", "0.093", "0.895", "0.443", "1.808", "0.757"], ["CEBPAdouble", "0.598", "0.286", "1.252", "0.173", "0.451", "0.137", "1.488", "0.191"], ["RUNX1", "1.532", "0.875", "2.683", "0.136", "1.432", "0.726", "2.821", "0.300"], ["MLL-PTD", "2.706", "1.263", "5.799", "0.010", "2.882", "1.077", "7.710", "0.035"], ["TP53", "1.918", "0.697", "5.283", "0.207", "3.030", "0.956", "9.608", "0.060"], ["Higher KIAA0125 expression§", "2.300", "1.569", "3.371", "<0.001", "2.188", "1.317", "3.636", "0.003"]], "row_count": 12, "column_count": 9, "numeric_cells": 76, "header_rows": 3, "locator": "section[10]/table-wrap[1]#Tab2"}}, {"id": "asset:table:pmid:33225420:3", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:0489e3386bf9793c70cbe77627aa29617cbd34e5c2ce50ba5cf7523ebec575aa", "bytes": 2800, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[11]/table-wrap[1]#Tab3", "version": null, "note": "Summary of the biological functions of the KIAA0125-associated genes that have been reported to be associated with prognosis or drug resistance in AML patients and their correlation values with KIAA0125 in ours and the TCGA cohorts", "structure": {"pmcid": "PMC7817567", "section_index": 11, "section_title": "Biological impacts of KIAA0125 in AML", "row_count": 16, "column_count": 6}, "table": {"label": "Table 3", "caption": "Summary of the biological functions of the KIAA0125-associated genes that have been reported to be associated with prognosis or drug resistance in AML patients and their correlation values with KIAA0125 in ours and the TCGA cohorts", "rows": [["Genes", "Correlation coefficient (p value)", "Association with leukemia"], ["NTUH", "TCGA"], ["SPINK2", "0.661", "(3.4E-45)", "0.5798", "(6.2E-15)", "Serine Peptidase Inhibitor; upregulation is associated with poor outcomes in adult patients with AML [30]; integrated into a 6-gene LSC score to identifies high risk pediatric AML [31]"], ["MAP7", "0.653", "1.0E-43", "0.696", "(<E-45)", "Microtubule-associated proteins, overexpressed in cytogenetically normal AML patients with dismal outcomes [32]"], ["HOPX", "0.619", "(2.6E-38)", "0.643", "(<E-45)", "The smallest homeodomain protein; higher expression predicts poor prognosis in de novo AML [33]"], ["MMRN1", "0.609", "(9.7E-37)", "0.597", "(<E-45)", "A member of the elastin microfibrillar interface protein; an adverse marker in both pediatric and adult AML [34]"], ["DNMT3B", "0.599", "(1.7E-35)", "0.631", "(<E-45)", "DNA methyltransferases; an important LSC marker [35–37]"], ["TCF4", "0.556", "(1.1E-29)", "0.626", "(<E-45)", "A transcription factor; predict outcome in RUNX1 mutated and translocated AML [38, 39]"], ["SLC38A1", "0.536", "(2.3E-27)", "0.585", "(<E-45)", "A glutamine amino acid transporter, overexpressed in AML patients with adverse clinical outcomes [40]"], ["DOCK1", "0.530", "(1.1E-26)", "0.597", "(5.9E-16)", "A novel class of guanine nucleotide exchange factors; high expression confers poor prognosis in AML [41]"], ["ARHGAP22", "0.519", "(1.5E-25)", "0.518", "(<E-45)", "Rho GTPase activating protein, incorporated in the 17-gene LSC score which predicts treatment response in AML [9]"], ["MN1", "0.502", "(1.1E-23)", "0.565", "(<E-45)", "A transcriptional coactivator, overexpression could induce AML in mice and predict ATRA resistance in human AML patients [42, 43]"], ["ABCG1", "0.504", "(6.7E-24)", "0.610", "(<E-45)", "Belongs to ATP-binding cassette (ABC) superfamily; responsible for important chemoresistance mechanism in AML [44–49]"], ["ABCA2", "0.367", "(1.5E-12)", "0.507", "(2.3E-11)", "Belongs to ATP-binding cassette (ABC) superfamily; a strong prognostic biomarker for multidrug resistance in pediatric acute lymphoblastic leukemia [44–49]"], ["ABCB1", "0.353", "(1.2E-11)", "0.364", "(5.2E-6)", "Belongs to ATP-binding cassette (ABC) superfamily; responsible for important chemoresistance mechanism in AML [44–49]"], ["ABCC1", "0.310", "(3.2E-9)", "0.458", "(5.2E-9)", "Belongs to ATP-binding cassette (ABC) superfamily; responsible for important chemoresistance mechanism in AML [44–49]"]], "row_count": 16, "column_count": 6, "numeric_cells": 72, "header_rows": 2, "locator": "section[11]/table-wrap[1]#Tab3"}}], "gaps": []}, "analysis": {"state": "partial", "methods": [{"id": "method-1", "family": "group_comparison", "specific": "mann_whitney", "label": "Group comparison", "dsl_operations": [], "missing_operations": ["group_comparison_mann_whitney"], "expressible": false, "parameters": {}, "data_shapes": ["two_or_more_groups_continuous"], "evidence": {"score": 0.8, "band": "high", "quote": "Mann-Whitney"}}, {"id": "method-2", "family": "group_comparison", "specific": "anova", "label": "Group comparison", "dsl_operations": ["group_summary", "welch_t", "bootstrap_mean_difference", "group_comparison_anova"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["two_or_more_groups_continuous"], "evidence": {"score": 0.8, "band": "high", "quote": "ANOVA"}}, {"id": "method-3", "family": "survival_analysis", "specific": "kaplan_meier", "label": "Survival analysis", "dsl_operations": ["survival_km"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["time_to_event_with_censoring"], "evidence": {"score": 0.8, "band": "high", "quote": "Kaplan-Meier"}}, {"id": "method-4", "family": "survival_analysis", "specific": "cox_proportional_hazards", "label": "Survival analysis", "dsl_operations": ["cox_ph"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["time_to_event_with_censoring"], "evidence": {"score": 0.8, "band": "high", "quote": "Cox proportional hazards"}}, {"id": "method-5", "family": "survival_analysis", "specific": "log_rank_test", "label": "Survival analysis", "dsl_operations": ["logrank_test"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["time_to_event_with_censoring"], "evidence": {"score": 0.8, "band": "high", "quote": "log-rank"}}, {"id": "method-6", "family": "contingency_analysis", "specific": "chi_square", "label": "Categorical (contingency table) analysis", "dsl_operations": ["chi_square_test"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["categorical_cross_tabulation"], "evidence": {"score": 0.8, "band": "high", "quote": "χ2"}}, {"id": "method-7", "family": null, "specific": null, "label": "Maximally selected rank statistics were used to determine the optimal KIAA0125-expression cutoff for separating high- and low-expression patient groups.", "dsl_operations": [], "missing_operations": [], "expressible": null, "parameters": {}, "data_shapes": [], "evidence": {"score": 1.0, "band": "verbatim", "quote": "To find the optimal cutoff for separating patient groups, we used maximally selected rank statistics implemented in the maxstat R package."}}], "targets": [], "gaps": ["method.reader_named_unmapped", "method.group_comparison_mann_whitney"]}, "capability": {"state": "complete", "requirements": [{"capability_id": "capability:computational_analysis", "label": "Computational analysis platform", "assay_families": ["meta_analysis", "machine_learning", "survival_analysis", "statistical_regression", "pca", "molecular_docking", "network_analysis", "differential_expression", "gwas"], "availability_state": "owned", "tier_unlocked": "R1", "candidate": "Automated Assays Laravel application and simulated adapters"}], "gaps": []}, "readiness": {"state": "blocked", "tier": "R4", "blocking_axis": "data", "blocked_on": "data:accession_absent", "axes": {"method": {"tier": "R1", "expressible": false, "required_operations": [], "missing_operations": ["group_comparison_mann_whitney"], "basis": "The paper names the method it used and the corpus's method extractor maps it onto the DSL catalogue: mann_whitney."}, "capability": {"tier": "R1", "capability_id": "capability:computational_analysis", "availability_state": "owned", "basis": "The computational analysis is owned. The physical bench the paper used is not, so a physical validation cannot be run here."}, "data": {"tier": "R4", "reachable": false, "accessions": ["GSE68469 and GSE71014", "GSE12417-GPL96"], "resolved_accessions": [], "statements": ["The raw and normalized microarray data reported in this article have been deposited in the Gene Expression Omnibus database (accession number GSE68469 and GSE71014)."], "basis": "The paper names GSE68469 and GSE71014, GSE12417-GPL96, but the accession does not resolve in the repository (no reason recorded, no reason recorded), so the data cannot be reached from here. No dataset was downloaded and no licence was read."}}, "can_run": {"dsl_operations": [], "assets": ["source:pmid:33225420", "asset:table:pmid:33225420:1", "asset:table:pmid:33225420:2", "asset:table:pmid:33225420:3"], "steps": []}, "must_build": {"dsl_operations": [{"operation": "group_comparison_mann_whitney", "unlocks_papers": null, "priority": null}], "converters": [], "readers": [], "capabilities": [], "data_gaps": ["data:geo:None"]}, "gaps": ["data:accession_absent"]}, "review": {"state": "partial", "machine_critique": {"kind": "extraction_review", "reader": {"model": "MiniMax-M3.1-Flash", "provider": "minimax", "provider_family": "minimax", "read_at": "2026-10-31T18:24:32Z", "independence": "single_reader"}, "evidence_check": {"method": "verbatim", "availability": "verbatim"}, "calls": 3, "usage": {"prompt_tokens": 38815, "completion_tokens": 1616, "cached_tokens": 793}}, "human_critique": null, "stages": [{"id": "extraction", "state": "complete", "reader": "MiniMax-M3.1-Flash", "provider": "minimax"}], "gaps": ["review.independent_reader", "review.machine_critique", "review.human_critique"]}, "execution": {"state": "absent", "status": "not_run", "mode": null, "runs": [], "gaps": ["execution.not_run"]}, "provenance": {"entities": [{"id": "pmid:33225420", "type": "paper", "label": "pmid:33225420"}, {"id": "source:pmid:33225420", "type": "manuscript", "label": "PMID 33225420 full text"}, {"id": "data:geo:None", "type": "dataset", "label": "GEO None"}], "activities": [{"id": "activity-reading-sci-2026-11-01", "type": "classification", "used": [{"id": "pmid:33225420", "type": "paper", "label": "pmid:33225420"}, {"id": "source:pmid:33225420", "type": "manuscript", "label": "PMID 33225420 full text"}, {"id": "data:geo:None", "type": "dataset", "label": "GEO None"}], "agent": "agent:corpus-assay-engine"}, {"id": "activity-read-33225420", "type": "extraction", "used": ["source:pmid:33225420"], "agent": "agent:minimax-reader"}, {"id": "activity-resolve-None", "type": "accession_resolution", "used": ["data:geo:None"], "agent": "agent:corpus-assay-engine"}], "agents": [{"id": "agent:corpus-assay-engine", "type": "software", "label": "Corpus assay engine"}, {"id": "agent:minimax-reader", "type": "software", "label": "MiniMax literature reader"}], "source_run_id": "reading-sci-2026-11-01", "dsl_catalogue_fingerprint": "343fb30756ba6ec3", "capability_table_fingerprint": "2cb3e42f047d2ecf", "snapshot_id": "ba34b49490d9bfaf"}, "lineage": {"parent_id": "pmid:33225420", "parent_hash": "sha256:438dfcd9610901565ae1f0822354b2b2195554ef2584e0879182db6bccd8f527", "fork_of": null, "generation": 6}, "gaps": ["execution.not_run", "method.group_comparison_mann_whitney", "method.reader_named_unmapped", "review.human_critique", "review.independent_reader", "review.machine_critique", "step:obtain_source_data blocked on data:accession_absent", "step:run_analysis blocked on method:group_comparison_mann_whitney"], "assays": [{"role": "data_generation", "definition_id": "amplicon_seq", "definition_version": "99e1195c7d6f", "definition_digest": null, "required_operations": [], "support_state": "partial", "source_hashes": {"assay_lexicon": "99e1195c7d6f"}, "confidence": 0.93, "evidence": ["participants. Analysis of gene expression in next-generation sequencing datasets We analyzed gene expression data of"], "order_basis": "paper_text_order:2797", "id": "assay:1"}, {"role": "data_generation", "definition_id": "rna_seq", "definition_version": "99e1195c7d6f", "definition_digest": null, "required_operations": [], "support_state": "partial", "source_hashes": {"assay_lexicon": "99e1195c7d6f"}, "confidence": 0.93, "evidence": ["mples profiled with Illumina Genome Analyzer RNA Sequencing in the TCGA database [30] to investigate the"], "order_basis": "paper_text_order:2924", "id": "assay:2"}, {"role": "analysis", "definition_id": "group_comparison", "definition_version": "f2132e96ae6c7a4e", "definition_digest": null, "required_operations": [], "support_state": "partial", "source_hashes": {"dsl_catalogue": "f2132e96ae6c7a4e"}, "confidence": 0.8, "evidence": ["Mann-Whitney"], "order_basis": "consumes_earlier_output", "id": "assay:3"}]}